Blume Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-180
Closed -$11.3K 394
2025
Q2
$11.3K Buy
+180
New +$10.8K ﹤0.01% 275
2018
Q2
Sell
-330
Closed -$10K 203
2018
Q1
$10K Sell
330
-870
-73% -$26.8K 0.01% 175
2017
Q4
$35K Hold
1,200
0.02% 144
2017
Q3
$33K Hold
1,200
0.02% 142
2017
Q2
$33K Hold
1,200
0.02% 122
2017
Q1
$30K Hold
1,200
0.02% 122
2016
Q4
$27K Hold
1,200
0.02% 125
2016
Q3
$29K Sell
1,200
-2,100
-64% -$50K 0.02% 115
2016
Q2
$75K Sell
3,300
-1,350
-29% -$29.2K 0.05% 78
2016
Q1
$95K Sell
4,650
-900
-16% -$17.5K 0.07% 70
2015
Q4
$113K Hold
5,550
0.08% 70
2015
Q3
$103K Hold
5,550
0.08% 63
2015
Q2
$111K Hold
5,550
0.08% 63
2015
Q1
$111K Hold
5,550
0.08% 76
2014
Q4
$105K Hold
5,550
0.07% 84
2014
Q3
$92K Hold
5,550
0.07% 71
2014
Q2
$94K Hold
5,550
0.07% 71
2014
Q1
$91K Buy
5,550
+900
+19% +$14.4K 0.07% 76
2013
Q4
$72K Buy
+4,650
New +$69.3K 0.06% 90

Other funds holding IHI

Blume Capital Management's IHI Position: Q3 2025 in Review

Blume Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 180 shares — an estimated $11.3K sold.

Blume Capital Management first reported a position in IHI in Q4 2013 and held it in 19 quarters. The position peaked at $113K in Q4 2015. 526 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

  • Blume Capital Management reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Blume Capital Management sold 180 iShares US Medical Devices ETF shares in Q3 2025, an estimated $11.3K.
  • Blume Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2013 and held it in 19 quarters.
  • Blume Capital Management's iShares US Medical Devices ETF position peaked at $113K in Q4 2015.
  • 526 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Blume Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.